IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies
Clinical trial NCT04153422 · RECRUITING
Trial details
- NCT number
- NCT04153422
- Sponsor
- Endeavor Health
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-15
- Primary completion
- 2027-08-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.